This page contains a Flash digital edition of a book.
73. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79, 2003. Consultation.


74. Joint WHO/FAO Expert Diet, Nutrition and the


75. Cerami A, Vlassara H, Brownlee M: Glucose and aging. Sci Am 256:90-96, 1987.76.


Prevention of Chronic Diseases. WHO Technical Report 916 (WHO 2003).


76. Cerami A: Hypothesis: glucose as a mediator of aging. J Amer Ger Soc 33:626-634, 1985.


77. Peppa M, Uribarri J, Vlassara H: Glucose, advanced glycation end products, and diabetic complications: What is new and what works. Clinical Diabetes 21:186-187, 2003.


78. Yudkin J: Hypertension and non-insulin dependent diabetes. BMJ 303: 730-732, 1991.


79. Yudkin J: Diet and coronary heart disease: why blame fat? J Roy Soc Med 85:515-516, 1992.


80. Preuss HG, Echard B, Bagchi D, Lieberman S, Perricone NV: Anti-


Zhuang C: Fraction S of maitake mushroom favorably inuences blood glucose levels and blood pressure in streptozotocin-induced diabetic rats. J Med Food 15:1-8, 2012.


81. Reiser S, Handler HB, Gadner LB, Hallfrisch JG, Michaelis OE 4th, Prather ES: Isocaloric exchanges of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am J Clin Nutr 32:2206-2216, 1979.


82. Hallfrisch J, Lazar F, Jorgensen C, Reiser S: Insulin and glucose res- ponse in rats fed sucrose or starch. Am J Clin Nutr. 32:787-793, 1979.


83. 8.5 the metabolic syndrome. Mediators Inamm. 20102010. pii: 289645. doi: 10.1155/2010/289645. Epub 2010 Jul 14.


aging nutraceuticals. In: Anti-Aging Therapeutics, (eds) R Klatz, R Goldman, 10:219-224, 2008.


84. Esser N, Legrand-Poels S, Piette J, Andr J. Scheen AJ, Paquot N: Inammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice 105:141- 150, 2014.


86. McPherson RA: Specic proteins. In: Clinical diagnosis and management, Henry JB, ed. Philadelphia: W. B. Saunders, pp 204 214, 1984. 


85. Pepys MB, Hirscheld GM: C-reactive protein: a critical update. The Journal of Clinical Investigation 111:18051812, 2003.


 Meets & Exceeds Core Curriculum Specifications for FMCSA/NRCME  Prepare for the National Registry Examination  Understand the Rules and Applications for BAT Testing  Accredited by PACE through NUHS


Join the Federal Motor Carrier Safety Association’s National University of Health Sciences & PACE LIVE STREAM SEMIN


September 23-24, 2016 F


r Sa Att endanc e wl


iday Sept. 2 , 5pm to 9pm turday Sept. 24, 9am to 1p


3 m il be electr nically monit o ored 100 % participation is re quir d e


8 Hour CE NCMRE Seminar


THE ORIGINAL INTERNIST JUNE 2016 


DOT MEDICAL EXAMINER 


 


89 AR


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52